Golden Arrow Merger, a blank check company targeting healthcare and healthcare-related infrastructure, filed on Wednesday with the SEC to raise up to $250 million in an initial public offering.
The New York, NY-based company plans to raise $250 million by offering 25 million units at $10. Each unit will consist of one share of common stock and one-third of a warrant, exercisable at $11.50. At the proposed deal size, Golden Arrow Merger will command a market value of $313 million.
The company is led by CEO and CFO Timothy Babich, who previously founded Nexxus Holdings, FCM Bank, and Fortelus Capital Management. He is joined by Chairman Jacob Doft, who co-founded Highline Capital Management and currently serves as CEO. Golden Arrow Merger intends to initially focus on identifying a prospective target business in the healthcare or healthcare-related infrastructure industries in the US and other developed countries.
Golden Arrow Merger was founded in 2020 and plans to list on the Nasdaq under the symbol GAMCU. It filed confidentially on January 22, 2021. BTIG is the sole bookrunner on the deal.
IPO Pro - "The Ultimate Resource for IPOs"
Don't risk buying another IPO without IPO Pro.
Get your FREE TRIAL now.
